Phentermine & Medication Weight Loss New/Follow Up Appointment $180 a Month Weight Loss Visit Includes: 30 Day Medication Blood Work & EKG (only new patient) Medical Evaluation Vitamin B12 Injection Nutrition Review Simple Exercise Regime Phentermine is FDA Approved for Weight Loss, all programs are contingent on medical approval following a medical evaluation $30 for Blood Work first visit if no insurance is used Wegovy (Semaglutide) & Mounjaro (Tirzepatide) Weight Loss Appointment In Office $75-$125 a Week 1 week of Injections Medical Evaluation Vitamin B12 Injection Monthly Nutrition Review Simple Exercise Regime Blood Work Wegovy & Zepbound are FDA approved for Weight Loss, all programs are contingent on medical approval following a medical evaluation $30 for Blood Work first visit with No Insurance Wegovy (Semaglutide) & Mounjaro (Tirzepatide) Weight Loss Appointment Take Home Injection $300-$500 a Month 1 Month of Injections Medical Evaluation Vitamin B12 Injection Nutrition Review Simple Exercise Regime Blood Work Wegovy & Zepbound are FDA approved for Weight Loss, all programs are contingent on medical approval following a medical evaluation $30 for Blood Work first visit with No Insurance Medication Weight Loss Oceans Weight Loss provides effective medical Weight Loss programs with Medications approved for Weight Loss SCHEDULE HERE WEIGHTLOSS INJECTIONS Mounjaro/Zepbound Tirzepatide Wegovy Semaglutide Ozempic SCHEDULE HERE Aesthetics Dermal Fillers, Lip Injections, Cheek Fillers We Offer a Wide Range of Aesthetic Services, feel free to Schedule online, call our office with questions or message us online

This form of B12 is most often used to treat serious or long term deficiencies
She can explain our protocols and fees in more detail, answer any questions or concerns you have, and explain how our approach can help you get to the root of your symptoms
Diabetes Management Only for Type 2 or 3 diabetes (not Type 1)
Brand-name medications such as Mounjaro may be prescribed when clinically appropriate
FDA has taken an important step toward expanding the regulatory pathway for testosterone therapy in men, focusing on improving treatment access for conditions linked to low testosterone levels